Professor, Internal Medicine, Hematology/Oncology, University of Michigan Medical School
Oncology
Dr. Jennifer J. Griggs, MD
|
|
Give Review
Jennifer Griggs is an expert in the field of Oncology. He went to University at Buffalo, School of Medicine and Biomedical Sciences. He received awards:"CMS Meaningful Use Stage 1 Certification", "Research League of Excellence", "Compassionate Doctor Recognition", "Patients' Choice Award", "Who's Who in America", "Best Doctors in America", "Best Mentor Award", "Advocate Spirit Award", "Jacob Gitelman Award for Outstanding Service to the Cancer Community", "Winner, Humanism in Medicine Award, AAMC", "Dentistry Nominee for the Association of American Medical Colleges Humanism in Medicine Award", "Resident Teaching Award", "Morgan Teaching Award", "Janet M. Glasgow Citation", "David Miller Award in Medicine", "Alpha Omega Alpha" and "Dean's Letter of Commendation". Dr. Jennifer J. Griggs is a published doctor. He published 92 publications, including: 'Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia.' Jennifer Griggs accepts Medicare payments and is listed with Medicare.gov.
Publications
- Clinical predictors of long-term survival in HER2-positive metastatic Breast cancer.
- Periodontal health, perceived oral health, and dental care utilization of Breast cancer survivors.
- Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the ...
- Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage Breast cancer.
- Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy.
- Providers of follow-up care in a population-based sample of Breast cancer survivors.
- Attitudes toward and use of Cancer management guidelines in a national sample of medical oncologists and surgeons.
- Health disparities and the Cancer survivor.
- Marginal treatment benefit in anaplastic thyroid Cancer.
- Variation in the management of thyroid Cancer.
- Physicians Criticizing Physicians to Patients.
- Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with Breast cancer.
- Referral Patterns for Patients with High-Risk Thyroid Cancer.
- Development of a Question Prompt List as a Communication Intervention to Reduce Racial Disparities in Cancer Treatment.
- Disease severity and radioactive iodine use for thyroid Cancer.
- The Relationship Between Extent of Thyroid Cancer Surgery and Use of Radioactive Iodine.
- The role of clinicians in determining radioactive iodine use for low-risk thyroid Cancer.
- Role of Nonclinical Factors in the Receipt of High-Quality Systemic Adjuvant Breast Cancer Treatment.
- American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women Wi...
- Do All Patients with Breast Cancer Require Systemic Adjuvant Therapy?
- Use of radioactive iodine for thyroid Cancer.
- Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy.
- Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.
- Structural Estimates of Treatment Effects on Outcomes Using Retrospective Data: An Application to Ductal Carcinoma In Situ.
- Correlates of worry about recurrence in a multiethnic population-based sample of women with Breast cancer.
- The impact of diabetes on survival in women with ovarian Cancer.
- Racial/ethnic differences in job loss for women with Breast cancer.
- Comparative effectiveness of ductal Carcinoma in situ management and the roles of margins and surgeons.
- Employment of nurse practitioners and physician assistants in Breast cancer care.
- Casting light on 25-hydroxyvitamin D deficiency in ovarian Cancer: a study from the NHANES.
- Does it matter where you go for Breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for Breast cancer.
- American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive Breast cancer.
- Adjuvant hormonal therapy for early-stage Breast cancer.
- Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for Breast cancer.
- Obesity and angiolymphatic invasion in primary Breast cancer.
- Coordinating cancer care: patient and practice management processes among surgeons who treat Breast cancer.
- Racial/ethnic differences in quality of life after diagnosis of Breast cancer.
- Surgeon recommendations and receipt of mastectomy for treatment of Breast cancer.
- Decision involvement and receipt of mastectomy among racially and ethnically diverse Breast cancer patients.
- The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment.
- Complexities of adjuvant endocrine therapy in young premenopausal women.
- Disparities in Breast cancer adjuvant chemotherapy: moving beyond yes or no.
- Postmastectomy radiotherapy for Breast cancer: patterns, correlates, communication, and insights into the decision process.
- Hot flashes, fatigue, treatment exposures and work productivity in Breast cancer survivors.
- Obesity and Cancer treatment: weighing the evidence.
- Racial/ethnic differences in adequacy of information and support for women with Breast cancer.
- Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice.
- Social and racial differences in selection of Breast cancer adjuvant chemotherapy regimens.
- Self-reported cognitive impairment in patients with Cancer.
- Effect of patient socioeconomic status and body mass index on the quality of Breast cancer adjuvant chemotherapy.
- Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate Cancer: identification of outcomes and costs.
- Undertreatment of obese women receiving Breast cancer chemotherapy.
- Epilepsy surgery and the racial divide.
- John Henryism--the same old song?
- Study protocol: a randomized controlled trial of patient navigation-activation to reduce Cancer health disparities.
- Perceptions of care coordination in a population-based sample of diverse Breast cancer patients.
- American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive Breast cancer.
- Patient-centered communication and prognosis discussions with Cancer patients.
- Latina patient perspectives about informed treatment decision making for Breast cancer.
- The impact of sociodemographic, treatment, and work support on missed work after Breast cancer diagnosis.
- Vitality, mental health, and satisfaction with information after Breast cancer.
- Physician ratings of patient literacy: bending over backwards?
- Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry.
- Patient-centered care and Breast cancer survivors'' satisfaction with information.
- Exercise and side effects among 749 patients during and after treatment for Cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.
- Stability of decisional role preference over the course of Cancer therapy.
- Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in Breast cancer patients receiving chemotherapy.
- Racial disparity in the dose and dose intensity of Breast cancer adjuvant chemotherapy.
- Pilot study using gabapentin for tamoxifen-induced hot flashes in women with Breast cancer.
- Cost effectiveness, chemotherapy, and the clinician.
- Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
- Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma.
- Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
- Reducing the toxicity of antiCancer therapy: new strategies.
- Economic analysis of expensive technologies: the case of erythropoietin.
- Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced Anemia.
- Family communication and mental health after Breast cancer.
- Personalized medicine: a perk of privilege?
- Race modifies the association between Breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu.
- Effect of gabapentin on nausea induced by chemotherapy in patients with Breast cancer.
- Patients' barriers to receipt of Cancer care, and factors associated with needing more assistance from a patient navigator.
- A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in Breast cancer.
- Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of Breast cancer patients.
- Decision-making role preferences of patients receiving adjuvant Cancer treatment: a university of Rochester Cancer center community clinical oncology program.
- Race/ethnicity-based concerns over understanding Cancer diagnosis and treatment plan.
- Disease-free probability after the first primary ductal carcinoma in situ of the Breast: a comparison between African-American and White-American women.
- Neuropathic pain associated with non-surgical treatment of Breast cancer.
- Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with Breast cancer.
- Use of antibiotics and risk of Cancer.
- Phase II study of low-dose infusional 5-fluorouracil and paclitaxel (Taxol) given every 2 weeks in metastatic Breast cancer.
- Skeletal muscle mass in an asymptomatic male.
Schools
State University of New York At Buffalo
Conditions Treated
- Anemia
- Breast Cancer
- Carcinoma in Situ
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Research League of Excellence
- Compassionate Doctor Recognition
- Patients' Choice Award
- Who's Who in America
- Best Doctors in America
- Best Mentor Award
- Advocate Spirit Award
- Jacob Gitelman Award for Outstanding Service to the Cancer Community
- Winner, Humanism in Medicine Award, AAMC
- Dentistry Nominee for the Association of American Medical Colleges Humanism in Medicine Award
- Resident Teaching Award
- Morgan Teaching Award
- Janet M. Glasgow Citation
- David Miller Award in Medicine
- Alpha Omega Alpha
- Dean's Letter of Commendation
Education
-
University of Rochester -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1700949609 | |
| NPPES Provider LastName | GRIGGS | |
| NPPES Provider FirstName | JENNIFER | |
| NPPES Provider ZIPCode | 481095916 | |
| NPPES Provider State | MI | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 235.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 5.96 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700949609 |
| Last Name Of The Provider | GRIGGS |
| First Name Of The Provider | JENNIFER |
| View All |
Similar Doctors
|
|
Dr. Rami N. Khoriaty, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis P. Worden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathalie A. Brophy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan G. Urba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen E. Bickel, MD |
|
|
Dr. Kunal C. Kadakia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Qing Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodora S. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Attaphol Pawarode, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip L. Palmbos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monika L. Burness, MD
This Doctor is OpenDoctor Recommended.
|